The latest announcement is out from OptimizeRx ( (OPRX) ).
On March 10, 2025, OptimizeRx Corporation announced the appointment of Stephen Silvestro as its new Chief Executive Officer. Silvestro, who has been with the company since 2019, brings over 20 years of experience in health technology and services. His leadership is expected to drive the next phase of the company’s growth, focusing on operational excellence and strategic partnerships. The appointment follows a rigorous search process and marks a pivotal moment for OptimizeRx as it aims to enhance its market position and shareholder value.
More about OptimizeRx
OptimizeRx is a leading healthcare technology company that connects life science brands with patients and healthcare providers. The company utilizes innovative AI-driven tools such as the Dynamic Audience Activation Platform and Micro-Neighborhood Targeting to deliver targeted engagement. OptimizeRx partners with pharmaceutical and life sciences companies to transform healthcare by providing synchronized marketing solutions that improve patient outcomes.
YTD Price Performance: -12.09%
Average Trading Volume: 184,341
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $84.37M
For a thorough assessment of OPRX stock, go to TipRanks’ Stock Analysis page.